Hutchison China Meditech Limited Share Price: HCM (Hutchison China Meditech Limited) Stock Price Today & Updates | INDmoney

Question 1

What is Hutchison China Meditech Limited share price today?

Accepted Answer

Hutchison China Meditech Limited (HCM) share price today is {{live_price}}.

Question 2

Can Indians buy Hutchison China Meditech Limited shares?

Accepted Answer

Yes, Indians can invest in the Hutchison China Meditech Limited (HCM) from India.

With INDmoney, you can buy Hutchison China Meditech Limited at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Hutchison China Meditech Limited at zero transaction cost.

Question 3

How can I buy Hutchison China Meditech Limited shares from India?

Accepted Answer

It is very easy to buy Hutchison China Meditech Limited from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Hutchison China Meditech Limited be purchased?

Accepted Answer

Yes, you can buy fractional shares of Hutchison China Meditech Limited with INDmoney app.

Question 5

What are the documents required to start investing in Hutchison China Meditech Limited stocks?

Accepted Answer

To start investing in Hutchison China Meditech Limited, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Hutchison China Meditech Limited

Accepted Answer

Today’s highest price of Hutchison China Meditech Limited (HCM) is {{1_rba_end}}.

Today’s lowest price of Hutchison China Meditech Limited (HCM) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Hutchison China Meditech Limited

Accepted Answer

Today's market capitalisation of Hutchison China Meditech Limited HCM is 3.1B

Question 8

What is the 52 Week High and Low Range of Hutchison China Meditech Limited

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Hutchison China Meditech Limited is down from its 52 Week High?

Accepted Answer

Hutchison China Meditech Limited (HCM) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Hutchison China Meditech Limited is up from its 52 Week low?

Accepted Answer

Hutchison China Meditech Limited (HCM) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Hutchison China Meditech Limited?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Hutchison China Meditech Limited

Accepted Answer

Dr. Wei-Guo  Su B.Sc., Ph.D. is the current Chief Executive Officer (CEO) of Hutchison China Meditech Limited.

Period	Hutchison China Meditech Limited	Sector (Health Care)	Index (Russel 2000)
3 Months	-1.17%	-6.9%	0.0%
6 Months	-10.16%	-1.7%	0.0%
1 Year	-3.07%	10.4%	0.0%
3 Years	-47.63%	8.8%	-24.1%

Market Capitalization	3.1B
Book Value	$0.87
Earnings Per Share (EPS)	-0.25
PEG Ratio	0.0
Wall Street Target Price	28.531

Profit Margin	-6.87%
Operating Margin TTM	-9.0%

Return On Assets TTM	-5.9%
Return On Equity TTM	-5.44%

Revenue TTM	610.8M
Revenue Per Share TTM	3.58
Quarterly Revenue Growth YOY	-42.6%
Gross Profit TTM	-271.6M
EBITDA	-110.2M
Diluted Eps TTM	-0.25
Quarterly Earnings Growth YOY	-0.84

Hutchison China Meditech Limited (HCM)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Increasing Revenue

Increasing Net Profit

Vs CTLT

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-0.23
EPS Estimate Next Year	0.2
EPS Estimate Current Quarter	0.0
EPS Estimate Next Quarter	0.0

	FY18	Y/Y Change
Revenue	214.1M	↓ 11.23%
Net Income	-74.8M	↑ 179.78%
Net Profit Margin	-34.94%	↓ 23.86%

	FY19	Y/Y Change
Revenue	204.9M	↓ 4.31%
Net Income	-144.4M	↑ 93.01%
Net Profit Margin	-70.47%	↓ 35.53%

	FY20	Y/Y Change
Revenue	228.0M	↑ 11.27%
Net Income	-194.6M	↑ 34.76%
Net Profit Margin	-85.34%	↓ 14.87%

	FY21	Y/Y Change
Revenue	356.1M	↑ 56.21%
Net Income	-227.7M	↑ 17.01%
Net Profit Margin	-63.93%	↑ 21.41%

	FY22	Y/Y Change
Revenue	426.4M	↑ 19.73%
Net Income	-410.1M	↑ 80.16%
Net Profit Margin	-96.18%	↓ 32.25%

	FY23	Y/Y Change
Revenue	838.0M	↑ 96.52%
Net Income	100.8M	↓ 124.57%
Net Profit Margin	12.03%	↑ 108.21%

	Q4 FY22	Q/Q Change
Revenue	112.2M	↑ 0.0%
Net Income	-99.0M	↑ 0.0%
Net Profit Margin	-88.24%	↑ 0.0%

	Q1 FY23	Q/Q Change
Revenue	266.4M	↑ 137.51%
Net Income	84.3M	↓ 185.14%
Net Profit Margin	31.63%	↑ 119.87%

	Q2 FY23	Q/Q Change
Revenue	532.9M	↑ 100.0%
Net Income	168.6M	↑ 100.0%
Net Profit Margin	31.63%	↑ 0.0%

	FY18	Y/Y Change
Total Assets	532.1M	↓ 11.01%
Total Liabilities	119.9M	↑ 6.11%

	FY19	Y/Y Change
Total Assets	465.1M	↓ 12.59%
Total Liabilities	152.2M	↑ 26.99%

	FY20	Y/Y Change
Total Assets	724.1M	↑ 55.68%
Total Liabilities	205.2M	↑ 34.79%

	FY21	Y/Y Change
Total Assets	1.4B	↑ 89.56%
Total Liabilities	333.1M	↑ 62.38%

	Q3 FY23	Q/Q Change
Revenue	152.6M	↓ 71.37%
Net Income	-33.9M	↓ 120.1%
Net Profit Margin	-22.21%	↓ 53.84%

	Q4 FY23	Q/Q Change
Revenue	152.8M	↑ 0.18%
Net Income	12.9M	↓ 138.07%
Net Profit Margin	8.44%	↑ 30.65%

	FY18	Y/Y Change
Operating Cash Flow	-32.8M	↑ 267.29%
Investing Cash Flow	43.8M	↓ 116.78%
Financing Cash Flow	-8.2M	↓ 103.01%

	FY19	Y/Y Change
Operating Cash Flow	-80.9M	↑ 146.33%
Investing Cash Flow	119.0M	↑ 172.05%
Financing Cash Flow	-1.5M	↓ 81.86%

	FY20	Y/Y Change
Operating Cash Flow	-62.1M	↓ 23.29%
Investing Cash Flow	-125.4M	↓ 205.39%
Financing Cash Flow	296.4M	↓ 19954.92%

	FY21	Y/Y Change
Operating Cash Flow	-204.2M	↑ 229.04%
Investing Cash Flow	-306.3M	↑ 144.19%
Financing Cash Flow	650.0M	↑ 119.28%

	FY22	Y/Y Change
Operating Cash Flow	-268.6M	↑ 31.52%
Investing Cash Flow	296.6M	↓ 196.82%
Financing Cash Flow	-82.8M	↓ 112.73%

	Q4 FY22	Q/Q Change
Operating Cash Flow	167.6M	↓ 287.52%
Investing Cash Flow	18.4M	↑ 0.0%
Financing Cash Flow	-766.6M	↑ 18770.68%

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Hutchison China Meditech Limited	-16.92%	-10.16%	-3.07%	-47.63%	-26.18%
Neurocrine Biosciences Inc.	7.04%	-10.35%	12.63%	45.35%	9.32%
Haleon Plc Spon Ads	-3.63%	12.35%	14.51%	28.88%	28.88%
Zoetis Inc.	-6.75%	2.71%	-1.47%	-21.23%	47.49%
Viatris Inc.	13.54%	21.84%	41.41%	0.99%	-18.91%
Catalent, Inc.	-0.43%	8.53%	50.66%	-53.63%	14.64%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Hutchison China Meditech Limited	30.0	NA	0.0	-0.23	-0.05	-0.06	NA	0.87
Neurocrine Biosciences Inc.	33.33	33.33	0.29	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	27.88	27.88	1.69	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	33.0	33.0	2.46	5.87	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.08	2.67	-0.04	0.02	0.04	16.58
Catalent, Inc.	211.02	NA	2.95	0.2	-0.11	0.0	NA	19.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Hutchison China Meditech Limited	Buy	$3.1B	-26.18%	30.0	-6.87%
Neurocrine Biosciences Inc.	Buy	$12.7B	9.32%	33.33	17.21%
Haleon Plc Spon Ads	Buy	$42.9B	28.88%	27.88	10.75%
Zoetis Inc.	Buy	$79.2B	47.49%	33.0	26.55%
Viatris Inc.	Hold	$15.1B	-18.91%	224.4	-5.87%
Catalent, Inc.	Hold	$10.7B	14.64%	211.02	-9.34%

Organization	Hutchison China Meditech Limited
Employees	1970
CEO	Dr. Wei-Guo Su B.Sc., Ph.D.
Industry	Health Technology